SRPT Jan 2026 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 04:14PM EDT. Market open.
| Previous close | 41.00 |
| Open | 41.00 |
| Bid | 57.00 |
| Ask | 62.00 |
| Strike | 70.00 |
| Expiry date | 2026-01-16 |
| Day's range | 41.00 - 41.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 8 |
ZacksSarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sarepta Therapeutics (SRPT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksSarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 763.64% and 10.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireSarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
CAMBRIDGE, Mass., May 01, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024.
© 2024 Yahoo. All rights reserved.